advertisement

---

Serle JB 11

Showing records 1 to 11 | Display all abstracts from Serle JB

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Ciolino JB
Ophthalmology 2016; 123: 2085-2092

---

69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Harris A
Journal of Glaucoma 2016; 25: e826-e833

---

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Ross AE
Ophthalmology 2016; 123: 2085-2092

---

69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Ward CL
Journal of Glaucoma 2016; 25: e826-e833

---

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Tulsan R
Ophthalmology 2016; 123: 2085-2092

---

69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Rowe-Rendleman CL; Ouchi T
Journal of Glaucoma 2016; 25: e826-e833

---

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Watts AC; Wang RF
Ophthalmology 2016; 123: 2085-2092

---

69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Wood A; Fujii A
Journal of Glaucoma 2016; 25: e826-e833

---

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Zurakowski D
Ophthalmology 2016; 123: 2085-2092

---

69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Serle JB
Journal of Glaucoma 2016; 25: e826-e833

---

70135 Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys
Serle JB; Kohane DS
Ophthalmology 2016; 123: 2085-2092

---